Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

被引：0
|
作者：
Robin Kate Kelley
Rebecca Miksad
Irfan Cicin
YenHsun Chen
Heinz-Josef Klümpen
Stefano Kim
Zhong-Zhe Lin
Jillian Youkstetter
Saswati Hazra
Suvajit Sen
Ann-Lii Cheng
Anthony B. El-Khoueiry
Tim Meyer
Ghassan K. Abou-Alfa
机构：
[1] UCSF Helen Diller Family Comprehensive Cancer Center,Royal Free Hospital
[2] Beth Israel Deaconess Medical Center,undefined
[3] Trakya University,undefined
[4] The Chinese University of Hong Kong,undefined
[5] Amsterdam University Medical Centers,undefined
[6] University of Amsterdam,undefined
[7] Centre Hospitalier Régional Universitaire de Besançon,undefined
[8] National Taiwan University Hospital,undefined
[9] Exelixis,undefined
[10] Inc,undefined
[11] USC Norris Comprehensive Cancer Center,undefined
[12] University College London,undefined
[13] Memorial Sloan Kettering Cancer Center,undefined
[14] Weill Medical College at Cornell University,undefined
[15] Flatiron Health,undefined
[16] Inc,undefined
[17] Boston Medical Center,undefined
来源：
British Journal of Cancer | 2022年 / 126卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：569 / 575
页数：6
相关论文
共 50 条
  • [1] Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
    Kelley, Robin Kate
    Miksad, Rebecca
    Cicin, Irfan
    Chen, YenHsun
    Klumpen, Heinz-Josef
    Kim, Stefano
    Lin, Zhong-Zhe
    Youkstetter, Jillian
    Hazra, Saswati
    Sen, Suvajit
    Cheng, Ann-Lii
    El-Khoueiry, Anthony B.
    Meyer, Tim
    Abou-Alfa, Ghassan K.
    [J]. BRITISH JOURNAL OF CANCER, 2022, 126 (04) : 569 - 575
  • [2] Outcomes based on albumin-bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Chan, S. L.
    Miksad, R.
    Cicin, I.
    Chen, Y.
    Klumpen, H. J.
    Kim, S.
    Lin, Z. Z.
    Youkstetter, J.
    Sen, S.
    Cheng, A-L.
    El-Khoueiry, A. B.
    Meyer, T.
    Kelley, R. K.
    Abou-Alfa, G. K.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [3] Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm
    kudo, Masatoshi
    [J]. LIVER CANCER, 2017, 6 (03) : 185 - 188
  • [4] Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
    Man, Zhong-Ran
    Gong, Xuan-Kun
    Qu, Kang-Lin
    Pang, Qing
    Wu, Bin-Quan
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (05)
  • [5] Postoperative albumin-bilirubin grade and albumin-bilirubin change predict the outcomes of hepatocellular carcinoma after hepatectomy
    Ye, Linsen
    Liang, Rongpu
    Zhang, Jiebin
    Chen, Chaojin
    Chen, Xiaolong
    Zhang, Yi
    Wang, Guoying
    Yang, Yang
    Chen, Guihua
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (16)
  • [6] Albumin-bilirubin grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
    Huo, Teh-Ia
    Ho, Shu Yein
    Liu, Po-Hong
    Hsu, Chia-Yang
    Huang, Yi-Hsaing
    Su, Chien-Wei
    Hou, Ming-Chih
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E837 - E838
  • [7] Outcomes based on albumin-bilirubin grade in the phase 3 RESORCE trial of regorafenib versus placebo in patients with advanced hepatocellular carcinoma
    Vogel, A.
    Merle, P.
    Granito, A.
    Ikeda, M.
    LeBerre, M. -A
    Ozgurdal, K.
    Bruix, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 223 - 223
  • [8] Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC)
    Miksad, R.
    Cicin, I.
    Chen, Y.
    Klumpen, H.
    Kim, S.
    Lin, Z.
    Youkstetter, J.
    Sen, S.
    Cheng, A.
    Meyer, T.
    Kelley, R.
    Abou-Alfa, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 134 - 134
  • [9] Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases
    Feng, Dayun
    Wang, Mengmeng
    Hu, Jie
    Li, Songlun
    Zhao, Shoujie
    Li, Huichen
    Liu, Lei
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (08)
  • [10] Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
    Hiraoka, Atsushi
    Kumada, Takashi
    Michitaka, Kojiro
    Toyoda, Hidenori
    Tada, Toshifumi
    Ueki, Hidetaro
    Kaneto, Miho
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Kawakami, Takamasa
    Kawamura, Tomoe
    Yamago, Hiroka
    Suga, Yoshifumi
    Miyamoto, Yuji
    Tomida, Hideomi
    Azemoto, Nobuaki
    Mori, Kenichiro
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 1031 - 1036
12345